Maxigen Biotech Inc Capital Reinvestment Ratio
Maxigen Biotech Inc capital reinvestment ratio. Maxigen Biotech Inc (1783) has a Capital Reinvestment Ratio of 0.23x as of June 2026, meaning it reinvests 0% of its operating cash flow (NT$74.75 Million) in capital expenditures (NT$17.01 Million). Check 1783 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Maxigen Biotech Inc (2009–2025)
Capital reinvestment ratio of Maxigen Biotech Inc from 2009 to 2025. This chart tracks Maxigen Biotech Inc's Capital Reinvestment Ratio across 12 annual periods. Also explore Maxigen Biotech Inc net asset momentum to track the company's year-over-year net asset growth rate.
Maxigen Biotech Inc Capital Reinvestment Ratio by Year (2009–2025)
Maxigen Biotech Inc capital reinvestment ratio by year from 2009 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Maxigen Biotech Inc.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | NT$290.22 Million | NT$82.63 Million | ▲ +167.3% |
| 2024 | 0.11x | NT$298.22 Million | NT$31.77 Million | ▼ -18.7% |
| 2023 | 0.13x | NT$171.20 Million | NT$22.44 Million | ▲ +143.6% |
| 2022 | 0.05x | NT$268.34 Million | NT$14.44 Million | ▼ -59.0% |
| 2021 | 0.13x | NT$117.59 Million | NT$15.45 Million | ▼ -13.8% |
| 2020 | 0.15x | NT$74.39 Million | NT$11.34 Million | ▼ -39.4% |
| 2019 | 0.25x | NT$94.42 Million | NT$23.74 Million | ▲ +112.0% |
| 2018 | 0.12x | NT$170.58 Million | NT$20.23 Million | ▼ -83.2% |
| 2017 | 0.70x | NT$41.18 Million | NT$29.01 Million | ▼ -66.4% |
| 2016 | 2.09x | NT$34.72 Million | NT$72.71 Million | ▲ +487.8% |
| 2012 | 0.36x | NT$17.53 Million | NT$6.24 Million | ▼ -9.9% |
| 2009 | 0.40x | NT$19.27 Million | NT$7.62 Million | — |